(Q33162514)

23 July 2017

Implantable cardioverter defibrillators in patients with cardiac amyloidosis (English)

1 reference

23 July 2017

1 reference

2

Angela Dispenzieri

1 reference

23 July 2017

3

Robert Kyle

1 reference

23 July 2017

Grace Lin

1

1 reference

PubMed ID

23489983

23 July 2017

Martha Grogan

series ordinal

4

1 reference

PubMed ID

23489983

23 July 2017

Peter A Brady

series ordinal

5

1 reference

23 July 2017

14 March 2013

1 reference

Journal of Cardiovascular Electrophysiology

23 July 2017

1 reference

23 July 2017

24

1 reference

23 July 2017

7

1 reference

23 July 2017

793-798

1 reference

Echocardiographic findings in systemic amyloidosis: spectrum of cardiac involvement and relation to survival.

23 July 2017

1 reference

Diagnosis and management of the cardiac amyloidoses

21 January 2018

1 reference

Senile systemic amyloidosis presenting with heart failure: a comparison with light chain-associated amyloidosis.

21 January 2018

1 reference

Prophylactic implantation of cardioverter-defibrillator in patients with severe cardiac amyloidosis and high risk for sudden cardiac death.

21 January 2018

1 reference

Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction

21 January 2018

1 reference

Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004.

21 January 2018

1 reference

Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: a staging system for primary systemic amyloidosis

21 January 2018

1 reference

Prognostication of survival using cardiac troponins and N-terminal pro-brain natriuretic peptide in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation

21 January 2018

1 reference

Frequency and causes of implantable cardioverter-defibrillator therapies: is device therapy proarrhythmic?

21 January 2018

1 reference

Death without prior appropriate implantable cardioverter-defibrillator therapy: a competing risk study

21 January 2018

1 reference

Patients at lower risk of arrhythmia recurrence: a subgroup in whom implantable defibrillators may not offer benefit. Antiarrhythmics Versus Implantable Defibrillator (AVID) Trial Investigators

21 January 2018

1 reference

A critical appraisal of implantable cardioverter-defibrillator therapy for the prevention of sudden cardiac death.

21 January 2018

1 reference

Independent predictors of survival in primary systemic (Al) amyloidosis, including cardiac biomarkers and left ventricular strain imaging: an observational cohort study

21 January 2018

1 reference

Features and prognosis of exertional syncope in light-chain associated AL cardiac amyloidosis

21 January 2018

1 reference

Systemic cardiac amyloidoses: disease profiles and clinical courses of the 3 main types.

21 January 2018

1 reference

Brugada syndrome: report of the second consensus conference: endorsed by the Heart Rhythm Society and the European Heart Rhythm Association.

21 January 2018

1 reference

Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy

21 January 2018

1 reference

Delayed complications following pacemaker implantation

21 January 2018

1 reference

Survival in patients with primary systemic amyloidosis and raised serum cardiac troponins

21 January 2018

1 reference

ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/JCE.12123

1 reference

23 July 2017

1 reference

PubMed ID

23489983